Bausch + Lomb Corporation (TSX:BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision® AREDS 2 Formula mini soft gels with OCUSorb™. This product is the only AREDS 2 eye vitamin with the OCUSorb formulation. Offering a proprietary composition of lutein and zeaxanthin, OCUSorb has been clinically shown to provide superior absorption of these nutrients into the body as compared to the original PreserVision AREDS 2 mini soft gel formula.
Asia Demand Momentum Boosts Fashion Brand Ralph Lauren’s Q2 Earnings; North America Wholesale Revenue Falls 7%
Ralph Lauren Corp (NYSE: RL) reported second-quarter FY24 sales growth of 3% year-on-year to $1.63 billion,
